During the past decade, Baylor College of Medicine/The Methodist Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor College of Medicine/The Methodist Hospital" #1 sponsor was "The Methodist Hospital Research Institute" with 10 trials, followed by "Medical College of Wisconsin" with 7 trials sponsored, "Actelion" with 3 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials sponsored and "Emory University" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine/The Methodist Hospital" #1 collaborator was "Blood and Marrow Transplant Clinical Trials Network" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Marrow Donor Program" with 8 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine/The Methodist Hospital" are "Carcinoma, Renal Cell" (5 trials), "Prostatic Neoplasms" (5 trials), "Pulmonary Arterial Hypertension" (3 trials), "Multiple Myeloma" (2 trials) and "Sickle Cell Disease" (2 trials). Many other conditions were trialed in "Baylor College of Medicine/The Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine/The Methodist Hospital" are "Drug" (18 trials), "Procedure" (5 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Tacrolimus" (2 trials), "Abraxane" (1 trials), "Alemtuzumab" (1 trials) and "Allogeneic Hematopoietic Cell Transplant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine/The Methodist Hospital" are 19 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Baylor College of Medicine/The Methodist Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Baylor College of Medicine/The Methodist Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine/The Methodist Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".